Neba Health

Neba Health is a medical technology company dedicated to improving the diagnostic process for neuropsychiatric disorders through objective biological measurements. The company's flagship product, the NEBA system, is an FDA-cleared diagnostic aid that uses electroencephalogram (EEG) technology to assist clinicians in evaluating ADHD in children and adolescents. By measuring the ratio of theta to beta brainwaves, the system provides a non-invasive biomarker that helps differentiate ADHD from other conditions with similar symptomatic presentations. This objective data is intended to be used in conjunction with standard clinical evaluations to increase diagnostic certainty. Neba Health's approach aims to reduce both over-diagnosis and under-diagnosis in the field of pediatric mental health.